|
|
Q-Med Ab - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Q-Med Ab Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Q-Med Ab. The Group's principal activities are the manufacturing, marketing and selling of medical implants based on the company's patented technology NASHA (Non-Animal Stabilized Hyaluronic Acid) to physicians, clinics and institutions. The Group operates through two segments: Esthetics and Hospital healthcare. The Esthetics segment manufactures products for the filling out of wrinkles and for the contouring of lips using Restylane. The Hospital healthcare segment manufactures products, which include ZUIDEX for the treatment of stress urinary incontinence in women, DEFLUX for the treatment of VUR (a malformation of the urinary bladder in children) and DUROLANE for the treatment of osteoarthritis of the knee and hip. The Group operates globally.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|